AzTrials
AzTrials

DementiaNCT05658666

Video Feedback Intervention in Nursing Home Residents With Dementia and Severe Challenging Behavior.

An observational study of Dementia and Nursing Home Resident, run by Radboud University Medical Center at 1 site in Netherlands.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to evaluate how, under what circumstances and for whom the video feedback intervention works for (the caregivers of) people with dementia and severe challenging behavior in a nursing home setting. Read more about this study

Who is it for?
Any age
What is being tested?
Video feedback intervention (in Dutch: Video Interventie Ouderenzorg)
How many people
25 participants
Where
1 siteNetherlands
Study dates
13 Dec 2022to 1 Jun 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: * Nursing home residents with dementia and severe challenging behavior where video feedback intervention is started by health care professionals as part of usual care. * Family caregivers of these nursing home resident * Involded professional caregivers

Who may be able to join

  • Nursing home resident
  • Dementia
  • Severe challenging behavior
  • Video feedback intervention is started by health care professionals as part of usual care

Who cannot join

  • N/A

Trial locations and contacts

1 site in 1 country.

Netherlands1 site, 1 recruiting
  • Expertise Centrum VIO de Wever, behandelcentrum de Hazelaar

    Tilburg, North Brabant, 5042 SE

    Inge Hageman, MA, 00316-18 72 75 88, i.hageman@dewever.nl

    Recruiting

Other trials in Netherlands

About this study

Official title: Leren Zien Wat Werkt: Video Interventie Ouderenzorg (VIO) Bij cliënten Met Dementie en Ernstig Probleemgedrag in Verpleeghuizen.

The purpose of this study is to evaluate how, under what circumstances and for whom the video feedback intervention works for (the caregivers of) people with dementia and severe challenging behavior in a nursing home setting.

Read the detailed description

This mixed multiple case study focuses on the evaluation of a video feedback intervention for (the caregivers of) people with dementia and challenging behavior. The video feedback intervention focuses on understanding the person with dementia, increasing the sense of competence in caregivers and improving their communication skills when interacting with the person with dementia. This realist evaluation aims to investigate what outcomes the intervention generates, for whom and in which contexts. Participants will receive care as usual.

Being tested
Video feedback intervention (in Dutch: Video Interventie Ouderenzorg)
Keywords
Video Feedback Intervention, Dementia, Challenging behavior, Nursing home
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Video feedback intervention (in Dutch: Video Interventie Ouderenzorg)Behavioural

    The video feedback trainer assesses the interaction between the person with dementia and the caregiver and acquires agreement from the caregiver on the goals of the intervention. Caregivers are trained during several feedback sessions using personal video footage of interaction between the person with dementia and the caregiver. The feedback focuses on basic interaction and attunement principles, and the team feeling competent. Recording starts with a nondemanding situation, enabling the caregiver to become aware of the principles they already apply and to learn how these principles can be used in more demanding situations. Subsequently, video footage is recorded in 1 to 3 situations, depending on the progress, of increasing difficulty, with about 4 weeks between 2 recordings. After each recording, a 1-hour feedback session is held. The intervention concludes with separate, 30-minute sessions for the formal and informal caregivers evaluating the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Changes in sense of competence of the professional caregiver

    Sense of competence in dementia care scale (SCIDS)

    Measured: 5 months

Secondary outcomes (8)
  1. Professional caregiver measures: changes in strain in dementia work

    Strain in dementia care scale (SDC)

    Measured: 5 months

  2. Professional caregiver measures: changes in safety in team participation

    Team climate inventory (TCI)

    Measured: 5 months

  3. Loved ones measures: changes in sense of competence

    Short sense of competence questionnaire (SSCQ)

    Measured: 5 months

  4. Person with dementia: changes in frequency of psychopathology

    Neuropsychiatric inventory nursing home (NPI-NH)

    Measured: 5 months

  5. Person with dementia: changes in severity of psychopathology

    Neuropsychiatric inventory nursing home (NPI-NH)

    Measured: 5 months

  6. Person with dementia: changes in frequency of agitated behaviors

    Cohen Mansfield Agitation Inventory (CMAI)

    Measured: 5 months

  7. Person with dementia: changes in quality of life

    Quality of life - Alzheimer Disease Scale (QOL-AD)

    Measured: 5 months

  8. Person with dementia: changes in social well-being

    Revised index for social engagement (RISE)

    Measured: 5 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Dec 2022
  2. Study start13 Dec 2022
  3. Primary completion1 Jun 2024 (estimated)
  4. Study completion1 Jun 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Cross-sectional
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05658666
Sponsor's protocol ID
111972
Status last verified
Aug 2022
First submitted
29 Nov 2022
Last updated
22 Dec 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Dementia and Nursing Home Resident, run by Radboud University Medical Center at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Debby Gerritsen (+31243618181, debby.gerritsen@radboudumc.nl), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Changes in sense of competence of the professional caregiver (time frame: 5 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in